Gelteq Limited

Historical price data

Gelteq Limited's mission is to revolutionize oral delivery by deploying its patented gel platform, which enhances solubility, absorption, and patient experience for pharmaceuticals and nutrients. Its key achievement is the development of a versatile, stable gel matrix in collaboration with Monash University, ranked #1 globally in pharmaceutical science. The company's strategy is to generate value through partnerships, licensing its technology, and co-developing products across healthcare, nutrition, and animal health sectors, without bearing the full cost of drug discovery.

A patented, customizable oral gel delivery platform that forms a stable matrix capable of combining water-soluble and lipid-soluble compounds, designed to improve bioavailability, patient adherence, and targeted release in the gastrointestinal tract.

Competes against large pharma internal teams, specialized CDMOs, and biotechs focused on oral delivery. Key differentiation is the gel's ability to combine incompatible compounds and its patient-centric design for swallowing ease. Primary challenge is scaling from a platform to commercially launched products.